[31-501-pm] Pharmacotherapies (Clinical) 1

[31-501-pm01S] Factors for continuation of Sacubitril Valsartan in patients with heart failure

○Erika Iwasaki¹, Noriko Kohyama², Mayumi Inamoto^1,3,4, Michiru Nagao^3,4, Tomiko Sunaga^4,5, Mio Ebato⁶, Hiroshi Suzuki⁶, Mari Kogo² (1. Grad. Sch. Pharm., Showa Univ., 2. Department of Clinical Pharmacy, Division of Pharmacotherapeutics, Showa University School of Pharmacy, 3. Department of Pharmacy, Showa University Fujigaoka Hospital, 4. Department of Hospital Pharmaceutics, Showa University School of Pharmacy, 5. Department of Pharmacy, Showa University Dental Hospital, 6. Department of Cardiovascular Medicine, Showa University Fujigaoka Hospital.)